Changes to the Code
H.R. 3082 · Evidence-Based Drug Policy Act of 2025 · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
21 U.S.C. § 1703 Appointment and duties of Director and Deputy Directors
+0 −5Shown
1 change the bill asks for here, 1 carried out
- Carried out:
Section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1703(b)(12)) is repealed.
§ 1703(b)Responsibilities(11)–(14)
Start of § 1703 to (b)(10) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (11) | (11) | (11) | ||
| may serve as spokesperson of the Administration on drug issues; | may serve as spokesperson of the Administration on drug issues; | |||
| (12) | (12) | (12) | ||
| (12)(A) | (A) | |||
| (12)(B) | (B) | |||
| (13) | (13) | (13) | ||
| Repealed. Pub. L. 115–271, title VIII, § 8221(b)(1)(A), Oct. 24, 2018, 132 Stat. 4142. | Repealed. Pub. L. 115–271, title VIII, § 8221(b)(1)(A), Oct. 24, 2018, 132 Stat. 4142. | |||
| (14) | (14) | (14) | ||
| shall submit to the appropriate congressional committees on an annual basis, not later than 60 days after the date of the last day of the applicable period, a summary of— | shall submit to the appropriate congressional committees on an annual basis, not later than 60 days after the date of the last day of the applicable period, a summary of— | |||
Rest of § 1703 unchanged